TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 36.15
-1.85 (-4.87%)
Mar 4, 2026, 11:02 AM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 956.47 million as of March 4, 2026. Its market cap has decreased by -35.45% in one year.
Market Cap
956.47M
Enterprise Value
105.60M
Revenue
324.73M
Ranking
n/a
PE Ratio
26.77
Stock Price
36.15
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 956.47M, a decrease of -55.20%. That is a compound annual growth rate of -17.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.01B | 7.04% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.31B |
| Meribank Biotech | 1.28B |
| GeneReach Biotechnology | 1.14B |
| Lukas Biomedical | 1.12B |
| Level Biotechnology | 1.09B |
| Holy Stone Healthcare | 1.02B |
| Taiwan Advance Bio-Pharmaceutical | 958.50M |
| NatureWise Biotech & Medicals | 944.75M |